ITX

54.8

+3.2%↑

ITX

54.8

+3.2%↑

ITX

54.8

+3.2%↑

ITX

54.8

+3.2%↑

ITX

54.8

+3.2%↑

Search

Evonik Industries AG

Slēgts

SektorsCikliskās patēriņa

16.93 -1.63

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

16.88

Max

17.07

Galvenie mērījumi

By Trading Economics

Ienākumi

174M

68M

Pārdošana

12M

3.4B

P/E

Sektora vidējais

30.607

44.566

EPS

0.15

Dividenžu ienesīgums

5.76

Peļņas marža

1.998

Darbinieki

28,650

EBITDA

-39M

367M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-5.71% downside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.76%

3.14%

Nākamie ieņēmumi

2026. g. 8. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.6B

8B

Iepriekšējā atvēršanas cena

18.56

Iepriekšējā slēgšanas cena

16.93

Ziņu noskaņojums

By Acuity

21%

79%

52 / 337 Rangs Consumer cyclical

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Evonik Industries AG Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 17. apr. 20:26 UTC

Iegādes, apvienošanās, pārņemšana

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

2026. g. 17. apr. 18:15 UTC

Galvenie ziņu notikumi

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

2026. g. 17. apr. 16:49 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

2026. g. 17. apr. 16:49 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

2026. g. 17. apr. 22:58 UTC

Peļņas

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

2026. g. 17. apr. 21:32 UTC

Tirgus saruna

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

2026. g. 17. apr. 21:22 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 17. apr. 21:22 UTC

Tirgus saruna

Moody's Downgrades Belgium to A1 -- Market Talk

2026. g. 17. apr. 20:52 UTC

Peļņas

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

2026. g. 17. apr. 20:50 UTC

Tirgus saruna
Peļņas
Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2026. g. 17. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 17. apr. 20:29 UTC

Peļņas

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

2026. g. 17. apr. 20:11 UTC

Iegādes, apvienošanās, pārņemšana

UCB to Buy Neurona Therapeutics for Up to $1.15B

2026. g. 17. apr. 19:34 UTC

Tirgus saruna
Peļņas
Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2026. g. 17. apr. 19:34 UTC

Tirgus saruna
Peļņas
Iegādes, apvienošanās, pārņemšana

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

2026. g. 17. apr. 19:31 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

2026. g. 17. apr. 19:26 UTC

Tirgus saruna

U.S. Natural Gas Futures Edge Up -- Market Talk

2026. g. 17. apr. 19:21 UTC

Tirgus saruna

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

2026. g. 17. apr. 19:15 UTC

Tirgus saruna

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

2026. g. 17. apr. 19:07 UTC

Tirgus saruna

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

2026. g. 17. apr. 18:57 UTC

Galvenie ziņu notikumi

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

2026. g. 17. apr. 18:53 UTC

Iegādes, apvienošanās, pārņemšana

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

2026. g. 17. apr. 18:53 UTC

Iegādes, apvienošanās, pārņemšana

UCB 2026 Rev Guidance Unchanged

2026. g. 17. apr. 18:52 UTC

Iegādes, apvienošanās, pārņemšana

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

2026. g. 17. apr. 18:52 UTC

Iegādes, apvienošanās, pārņemšana

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

2026. g. 17. apr. 18:14 UTC

Tirgus saruna
Galvenie ziņu notikumi

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

2026. g. 17. apr. 18:00 UTC

Galvenie ziņu notikumi

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

2026. g. 17. apr. 18:00 UTC

Galvenie ziņu notikumi

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

2026. g. 17. apr. 17:31 UTC

Tirgus saruna
Galvenie ziņu notikumi

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

2026. g. 17. apr. 17:26 UTC

Tirgus saruna
Peļņas

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Salīdzinājums

Cenas izmaiņa

Evonik Industries AG Prognoze

Cenas mērķis

By TipRanks

-5.71% uz leju

Prognoze 12 mēnešiem

Vidējais 16.02 EUR  -5.71%

Augstākais 20.4 EUR

Zemākais 12.7 EUR

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Evonik Industries AG — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

12 ratings

3

Pirkt

7

Turēt

2

Pārdot

Tehniskais rādītājs

By Trading Central

19.83 / 20Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Noskaņojums

By Acuity

52 / 337 Rangs Cikliskās patēriņa

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Evonik Industries AG

Evonik Industries AG produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides additives for polyurethane; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants, and viscosity index improvers for coatings for oil and other lubricants for construction machinery and automotive sector. The Nutrition & Care segment offers D-/l-methionine and lysine for animal nutrition industry; amino acids and peptides; pharmaceutical active ingredients; and biocompatible and bioresorbable materials for orthopedic and medical applications; and system solutions for the cosmetics and detergent industries. The Smart Materials segment provides inorganic materials, including fumed and precipitated silicas and silanes; peroxides for paper and textile industries; specialty catalysts for synthesis and alkoxides; polymers products, such as polymide 12, polymer foam, specialty polybutadiene and polyester, alkoxides, and membranes. The Performance Materials offers C4 derivatives consisting of butadiene, MTBE, butene-1, isononanol, and DINP for use in automotive industry; and superabsorbent products for diapers and hygiene products. The Technology & Infrastructure segment provides energy management, integrated plant support and maintenance, process safety and engineering, pipelines, transport management, logistics safety, digital solutions for chemical production, and strategic site development services. The company was founded in 1873 and is headquartered in Essen, Germany.
help-icon Live chat